HCW Biologics Inc. (HCWB) is up 71.3% today. Here is some analysis on what might have caused this price movement.
Analysis: There does not appear to be a single, widely-circulated fundamental headline driving today’s jump, so the move looks consistent with micro-cap biotech volatility and a momentum/positioning-driven squeeze. This could be tied to traders re-rating the risk after the company recently regained Nasdaq continued-listing compliance and after a discounted unit financing reset near prior lows.
Details:
Sources:
Company press release, SEC (EDGAR), TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$HCWB Hedge Fund Activity
We have seen 8 institutional investors add shares of $HCWB stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 300,180 shares (+inf%) to their portfolio in Q4 2025, for an estimated $291,354
- DRW SECURITIES, LLC removed 48,155 shares (-57.7%) from their portfolio in Q4 2025, for an estimated $46,739
- CITADEL ADVISORS LLC added 22,158 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,506
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 20,071 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,480
- J.W. COLE ADVISORS, INC. added 12,500 shares (+inf%) to their portfolio in Q4 2025, for an estimated $12,132
- GEODE CAPITAL MANAGEMENT, LLC added 3,036 shares (+27.6%) to their portfolio in Q4 2025, for an estimated $2,946
- TOWER RESEARCH CAPITAL LLC (TRC) added 2,942 shares (+188.3%) to their portfolio in Q4 2025, for an estimated $2,855
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
